| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 6 |
| 1 | FLUDARABINE PHOSPHATE | 5 |
| 2 | VEDOLIZUMAB | 5 |
| 3 | CYCLOPHOSPHAMIDE | 4 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 4 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 4 |
| 6 | METHOTREXATE | 4 |
| 7 | METHOTREXATE SODIUM | 4 |
| 8 | SIROLIMUS | 4 |
| 9 | ACYCLOVIR | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IDARUBICIN HYDROCHLORIDE | 1 | 0.0009 |
| 1 | RASBURICASE | 1 | 0.0004 |
| 2 | SIROLIMUS | 4 | 0.0003 |
| 3 | DOLUTEGRAVIR SODIUM | 2 | 0.0002 |
| 4 | GLATIRAMER ACETATE INJECTION | 1 | 0.0002 |
| 5 | FINGOLIMOD HYDROCHLORIDE | 1 | 0.0002 |
| 6 | MITOXANTRONE HYDROCHLORIDE | 1 | 0.0002 |
| 7 | FLUDARABINE PHOSPHATE | 5 | 0.0001 |
| 8 | DEXAMETHASONE SODIUM PHOSPHATE | 1 | 0.0001 |
| 9 | EFAVIRENZ | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 1 | 0.0001 |
| 1 | Integrin Receptor Antagonist [EPC] | 5 | 0.0001 |
| 2 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Complement Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Leukotriene Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | Interleukin-12 Antagonist [EPC] | 3 | 0.0000 |
| 6 | Interleukin-23 Antagonist [EPC] | 3 | 0.0000 |
| 7 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 3 | 0.0000 |